Table 2 Unit costs of antiretroviral agents

FDCs

Atripla^TM (TDF / emtricitabine / efavirenz: 245 / 200 / 600 mg), 30 tablets

701.08

Combivir^TM (zidovudine / lamivudine: 300 / 150 mg), 60 tablets

290.41

Kaletra^TM (lopinavir / ritonavir: 200 / 50 mg), 120 tablets

400.02

Kivexa^TM (lamivudine / abacavir: 300 / 600 mg), 30 tablets

355.54

Trizivir^TM (zidovudine / lamivudine / abacavir: 300 / 150 / 300 mg), 60 tablets

490.32

Truvada^TM (TDF / emtricitabine: 200 / 245 mg), 30 tablets

432.73

Individual antiretroviral components of FDCs

Generic lamivudine (300 mg), 30 tablets

62.76

Sustiva^TM (efavirenz: 600 mg), 30 tablets

265.03

Viread^TM (TDF: 250 mg), 30 tablets

288.70

Ziagen^TM (abacavir: 300 mg), 60 tablets

225.69

Generic zidovudine (300 mg), 300 tablets

403.15

Other antiretroviral agents employed in addition to FDCs

Intelence^TM (etravirine: 100 mg), 120 tablets

450.00

Isentress^TM (raltegravir: 400 mg), 60 tablets

690.00

Norvir^TM (ritonavir: 100 mg), 30 tablets

22.46

Prezista^TM (darunavir: 400 mg), 60 tablets

427.21

Reyataz^TM (atazanavir: 200 mg), 60 tablets

436.59

Reyataz^TM (atazanavir: 300 mg), 30 tablets

436.59

Telzir^TM (fosamprenavir: 700 mg), 60 tablets

316.89

Viramune^TM (nevirapine: 200 mg), 60 tablets

199.69